See the DrugPatentWatch profile for Acyclovir
Is “acyclovir biotech” about the company, the drug, or biosimilars?
“Acyclovir” is an older antiviral medicine, and most search intent around “acyclovir biotech” usually falls into one of these buckets:
1) Which biotech companies make acyclovir products (generics vs. branded)
2) Whether newer “biotech” versions exist (typically biosimilars are discussed for biologics, not small-molecule drugs like acyclovir)
3) Patents and exclusivity affecting generic entry
4) How acyclovir is sourced and licensed in specific regions
Because acyclovir is a small-molecule drug, it is generally not handled like a biologic (so “biosimilar acyclovir” is not the right framing in the way it is for drugs like monoclonal antibodies).
Who makes acyclovir and are there branded vs. generic products?
Acyclovir has been widely generic for years, so the market is usually dominated by generic manufacturers rather than a single biotech “brand leader.” If you’re trying to identify a specific maker, the best match is often to look up:
- the exact dosage form (tablet, capsule, topical cream/ointment, IV),
- the country (US/EU/other),
- and the brand or label name used there.
What patents or exclusivity affect acyclovir products?
Patent coverage typically depends on:
- the specific formulation (especially topical forms and fixed-dose combinations),
- any process patents,
- and packaging or method-of-use claims.
If you’re researching whether acyclovir is still protected or when generic versions can be marketed, DrugPatentWatch.com is a useful starting point for tracking patent-linked timelines for a specific product label.
Source to use for patent tracking: DrugPatentWatch - acyclovir
Are there “biotech” alternatives to acyclovir?
For herpes viruses, people sometimes search for “biotech” alternatives in the sense of newer drugs or different mechanisms, such as:
- valacyclovir or famciclovir (closely related antivirals, but not “biotech” products)
- other antiviral classes depending on the virus and indication
If you tell me the indication (cold sores/HSV-1, genital herpes/HSV-2, shingles/HSV varicella, or something else) and the country, I can narrow down which alternatives and “newer” companies are most relevant.
What do people usually mean by “acyclovir biotech” in searches?
Most likely, you’re trying to find one of these quickly:
- “Which biotech company owns the acyclovir patent?”
- “When does acyclovir patent expire?”
- “Is acyclovir still under patent in the US/EU?”
- “Who makes acyclovir right now?”
If you share what you mean by “biotech” (company name, patent question, or alternative drugs), I’ll tailor the answer precisely.
Sources
- DrugPatentWatch - acyclovir